Exclusive: Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual>It expects revenue in the range of $78 billion to $80 billion, up from its previous estimate of $70.5 billion to $72.5 billion. Shares of Pfizer rose 2.5% in intraday trading. “The second quarter was remarkable in a number of ways,” Pfizer CEO Albert Bourla said in a statement.
Exclusive: Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual>It expects revenue in the range of $78 billion to $80 billion, up from its previous estimate of $70.5 billion to $72.5 billion. Shares of Pfizer rose 2.5% in intraday trading. “The second quarter was remarkable in a number of ways,” Pfizer CEO Albert Bourla said in a statement.
Exclusive: Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual>It expects revenue in the range of $78 billion to $80 billion, up from its previous estimate of $70.5 billion to $72.5 billion. Shares of Pfizer rose 2.5% in intraday trading. “The second quarter was remarkable in a number of ways,” Pfizer CEO Albert Bourla said in a statement.
Are the 3 vaxx companies all owned by jewish folks? Asking for a friend.